Capital Flow Monitor · Sponsors · CIK 1075880
KAZIA THERAPEUTICS LTD
THREE INTERNATIONAL TOWERS LEVEL 24,, SYDNEY NSW, C3, 2000 · 01161298780088
Biotechnology · Corporation· inc. AUSTRALIA true
Fit score
—
Offering
$55.3M
Sold
$55.3M
% sold
100.0%
Investors
65
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | D ·current | 506(b) | $55.3M | $55.3M | 100.0% | 65 | EDGAR ↗ |
| 2025-08-14 | D | 506(b) | $2.1M | $2.1M | 100.0% | 4 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- John Friend — Executive Officer, Sydney, C3
- Bryce Carmine — Director, Sydney, C3
- Steven Coffey — Director, Sydney, C3
- Ebru Davidson — Director, Sydney, C3
-
Robert Apple — Director, Sydney, C3
1 other raise
- MASTEC INC $484.4M of $484.4M · 100.0%
- Jeffrey Bonacorda — Executive Officer, Sydney, C3
- Elissa Hansen — Executive Officer, Sydney, C3
Placement agents
- T.r. Winston & Company Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.